After months spent in discussion, debate in open forums and behind closed doors, the rule changing the allowable therapeutic non-steroidal anti-inflammatory drugs from two to one passed with a seeming collective sigh of relief at the U.S. Equestrian Federation Board of Directors meeting today, Jan. 17, in Louisville, Ky.
In a nutshell, the two new changes to GR 410 Equine Drugs and Medications will work in concert to allow an interim time to collect data and educate the membership. But effective Dec. 1, 2011, only one NSAID will be permitted.
Other details include:
By submitting your email, you agree to our Terms of Service and Privacy Policy. You may also receive promotional emails from The Chronicle of the Horse. You can opt out at any time.
For Customers
Company
Terms of Use
